Prolyl Isomerase Pin1 Expression in the Spinal Motor Neurons of Patients With Sporadic Amyotrophic Lateral Sclerosis
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and Purpose Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disease. Selective deficiency of edited adenosine deaminase acting on RNA 2 (ADAR2), a key molecule in the acquisition of Ca2+ resistance in motor neurons, has been reported in sporadic ALS (sALS) spinal motor neurons. Since ADAR2 activity is positively regulated by prolyl isomerase Protein never in mitosis gene A interacting-1 (Pin1), a known phosphorylation-dependent peptidyl-prolyl cis/trans isomerase, we investigated Pin1 expression in spinal motor neurons in sALS. Methods Specimens of the spinal cord were obtained from the lumbar region in eight sALS patients and age-matched five controls after postmortem examinations. The specimens were double stained with anti-Pin1 and anti-TAR DNA-binding protein of 43 kDa (TDP-43) antibodies, and examined under a fluorescence microscope. Results This study analyzed 254 and 422 spinal motor neurons from 8 sALS patients and 5 control subjects, respectively. The frequency of motor neurons with high cytoplasmic Pin1 expression from the spinal cord did not differ significantly between sALS specimens without cytoplasmic TDP-43 inclusions and control specimens. However, in sALS specimens, neurons for which the Pin1 immunoluminescence intensity in the cytoplasm was at least twice that in the background were more common in specimens with cytoplasmic TDP-43 inclusions (p<0.05 in χ2 test). Conclusions In sALS, neurons with higher expression levels of Pin1 levels had more TDP-43 inclusions. Despite the feedback mechanism between Pin1 and ADAR2 being unclear, since Pin1 positively regulates ADAR2, our results suggest that higher Pin1 expression levels in motor neurons with TDP-43 pathology from sALS patients represent a compensatory mechanism
Abstract
Background and Purpose Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disease. Selective deficiency of edited adenosine deaminase acting on RNA 2 (ADAR2), a key molecule in the acquisition of Ca2+ resistance in motor neurons, has been reported in sporadic ALS (sALS) spinal motor neurons. Since ADAR2 activity is positively regulated by prolyl isomerase Protein never in mitosis gene A interacting-1 (Pin1), a known phosphorylation-dependent peptidyl-prolyl cis/trans isomerase, we investigated Pin1 expression in spinal motor neurons in sALS. Methods Specimens of the spinal cord were obtained from the lumbar region in eight sALS patients and age-matched five controls after postmortem examinations. The specimens were double stained with anti-Pin1 and anti-TAR DNA-binding protein of 43 kDa (TDP-43) antibodies, and examined under a fluorescence microscope. Results This study analyzed 254 and 422 spinal motor neurons from 8 sALS patients and 5 control subjects, respectively. The frequency of motor neurons with high cytoplasmic Pin1 expression from the spinal cord did not differ significantly between sALS specimens without cytoplasmic TDP-43 inclusions and control specimens. However, in sALS specimens, neurons for which the Pin1 immunoluminescence intensity in the cytoplasm was at least twice that in the background were more common in specimens with cytoplasmic TDP-43 inclusions (p<0.05 in χ2 test). Conclusions In sALS, neurons with higher expression levels of Pin1 levels had more TDP-43 inclusions. Despite the feedback mechanism between Pin1 and ADAR2 being unclear, since Pin1 positively regulates ADAR2, our results suggest that higher Pin1 expression levels in motor neurons with TDP-43 pathology from sALS patients represent a compensatory mechanism
참고문헌 (17)
- Arai T, "TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis", Biochem Biophys Res Commun, 351, pp.602~611 (2006)
- Neumann M, "Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis", Science, 314, pp.130~133 (2006)
- Hideyama T, "Profound downregulation of the RNA editing enzyme ADAR2in ALS spinal motor neurons", Neurobiol Dis, 45, pp.1121~1128 (2012)
- Melcher T, "A mammalian RNA editing enzyme", Nature, 379, pp.460~464 (1996)
- Takuma H, "Reduction of GluR2RNA editing, a molecular change that increases calcium influx through AMPA receptors, selective in the spinal ventral gray of patients with amyotrophic lateral sclerosis", Ann Neurol, 46, pp.806~815 (1999)
- Kawahara Y, "Glutamate receptors : RNA editing and death of motor neurons", Nature, 427, pp.801~ (2004)
- Hideyama T, "Induced loss of ADAR2 engenders slow death of motor neurons from Q", R site-unedited GluR2, 2010, pp.30, 11917~11925
- Aizawa H, "TDP-43 pathology in sporadic ALS occurs in motor neurons lacking the RNA editing enzyme ADAR2", Acta Neuropathol, 120, pp.75~84 (2010)
- Yamashita T, "A role for calpain-dependent cleavage of TDP-43 in amyotrophic lateral sclerosis pathology", Nat Commun, 3, pp.1307~ (2012)
- Marcucci R, "Pin1 and WWP2 regulate GluR2 Q", R site RNA editing by ADAR2 with opposing effects, 2011, pp.30, 4211~4222
- Lu PJ, "Function of WW domains as phosphoserine-or phosphothreonine-binding modules", Science, 283, pp.1325~1328 (1999)
- Li J, "Roles of peptidyl-prolyl isomerase Pin1 in disease pathogenesis", Theranostics, 11, pp.3348~3358 (2021)
- Nakamura K, "Prolyl isomerase Pin1 regulates neuronal differentiation via β-catenin", Mol Cell Biol, 32, pp.2966~2978 (2012)
- Liou YC, "Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration", Nature, 424, pp.556~561 (2003)
- Wang L, "Peptidyl-prolyl cis", trans isomerase Pin1 and Alzheimer’s disease, 2020, pp.8, 355~
- Ryo A, "Prolylisomerase Pin1 accumulates in lewy bodies of parkinson disease and facilitates formation of alpha-synuclein inclusions", J Biol Chem, 281, pp.4117~4125 (2006)
- Iridoy MO, "Neuroanatomical quantitative proteomics reveals common pathogenic biological routes between amyotrophic lateral sclerosis(ALS)and frontotemporal dementia(FTD)", Int J Mol Sci, 20, pp.4~ (2018)